Objectives: To determine the relationship between preadmission glycemia, reflected by hemoglobin A1c level, glucose metrics, and mortality in critically ill patients. Design: Retrospective cohort investigation. Setting: University affiliated adult medical-surgical ICU. Patients: The investigation included 5,567 critically ill patients with four or more blood glucose tests and hemoglobin A1c level admitted between October 11, 2011 and November 30, 2019. The target blood glucose level was 90–120 mg/dL for patients admitted before September 14, 2014 (n = 1,614) and 80–140 mg/dL or 110–160 mg/dL for patients with hemoglobin A1c less than 7% or greater than or equal to 7% (n = 3,953), respectively, subsequently. Interventions: None. Measurements and Main Results: Patients were stratified by hemoglobin A1c: less than 6.5.(n = 4,406), 6.5–7.9% (n = 711), and greater than or equal to 8.0% (n = 450). Increasing hemoglobin A1c levels were associated with significant increases in mean glycemia, glucose variability, as measured by coefficient of variation, and hypoglycemia (p for trend < 0.0001, < 0.0001, and 0.0010, respectively). Among patients with hemoglobin A1c less than 6.5%, mortality increased as mean glycemia increased; however, among patients with hemoglobin A1c greater than or equal to 8.0%, the opposite relationship was observed (p for trend < 0.0001 and 0.0027, respectively). Increasing glucose variability was independently associated with increasing mortality only among patients with hemoglobin A1c less than 6.5%. Hypoglycemia was independently associated with higher mortality among patients with hemoglobin A1c less than 6.5% and 6.5–7.9% but not among those with hemoglobin A1c greater than or equal to 8.0%. Mean blood glucose 140–180 and greater than or equal to 180 mg/dL were independently associated with higher mortality among patients with hemoglobin A1c less than 6.5% (p < 0.0001 for each). Among patients with hemoglobin A1c greater than or equal to 8.0% treated in the second era, mean blood glucose greater than or equal to 180 mg/dL was independently associated with decreased risk of mortality (p = 0.0358). Conclusions: Preadmission glycemia, reflected by hemoglobin A1c obtained at the onset of ICU admission, has a significant effect on the relationship of ICU glycemia to mortality. The different responses to increasing mean glycemia support a personalized approach to glucose control practices in the ICU.

morphine on day 2 (71.9mg vs. 134.3mg) and day 3 (58.3mg vs 125.3mg); and for propofol on day 1 (1134.0mg v 1692.1mg) and day 3 (1208.7mg vs 2053.4mg). Time series analysis demonstrated a sharp increase in the proportion of patients over-sedated on days 1-3 for the 2 months following the move to single rooms; this decreased over the subsequent 10 months. Conclusion:Moving from an open plan to a single room environment may contribute to perceptions of increased personal and patient risk which results in administration of higher levels of sedation medication. In our context initial over-sedation corrected over time to be similar to pre-move levels.